Case series of long-term macrolide therapy effect on eosinophil count in COPD

Case series of long-term macrolide therapy effect on eosinophil count in COPD

Bibliographic Details
Main Authors:	Asciak, R, Thulborn, S, Bafadhel, M
Format:	Conference item
Published:	European Respiratory Society 2017

Similar Items

Investigating blood eosinophil count thresholds in patients with COPD
by: Russell, R, et al.
Published: (2018)

Effects of long-term macrolide therapy at low doses in stable COPD
by: Cao Y, et al.
Published: (2019-06-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
by: Shrimanker, R, et al.
Published: (2017)

Blood eosinophil count and exacerbation risk in patients with COPD.
by: Kerkhof, M, et al.
Published: (2017)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

Eosinophils in COPD: just another biomarker?
by: Bafadhel, M, et al.
Published: (2017)

The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis
by: Kazunori Nakamura, et al.
Published: (2023-10-01)

Blood eosinophil count and GOLD stage predict response to maintenance azithromycin treatment in COPD patients with frequent exacerbations
by: Djamin, R, et al.
Published: (2019)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
by: Lababidi, R, et al.
Published: (2017)

Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)

Blood eosinophil count as a prognostic biomarker in COPD
by: Oh YM, et al.
Published: (2018-10-01)

Antimicrobial peptides in inflammatory phenotypes of COPD
by: Cane, J, et al.
Published: (2017)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
by: Bafadhel, M, et al.
Published: (2014)

Predicting inhaled steroid responsiveness using blood eosinophil counts: personalising long-term management of COPD in primary care
by: Ashdown, HF
Published: (2019)

Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
by: Tomoki Maetani, et al.
Published: (2023-10-01)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
by: Benson VS, et al.
Published: (2019-11-01)

Current smoking reduces small airway eosinophil counts in COPD
by: Augusta Beech, et al.
Published: (2024-01-01)

Prediction value of neutrophil and eosinophil count at risk of COPD exacerbation
by: Tzu-Tao Chen, et al.
Published: (2023-12-01)

Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)
by: Bafadhel, M, et al.
Published: (2018)

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
by: Hambleton, K, et al.
Published: (2016)

Low-dose, long-term macrolide therapy in asthma: An overview
by: Rubinstein Israel, et al.
Published: (2004-03-01)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
by: Hambleton, K, et al.
Published: (2017)

Association between blood eosinophil count and risk of exacerbations in patients with COPD
by: Kerkhof, M, et al.
Published: (2017)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
by: Greulich T, et al.
Published: (2018-09-01)

Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis
by: Cui Y, et al.
Published: (2018-11-01)

Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
by: Helen F. Ashdown, et al.
Published: (2021-02-01)

Identification of COPD Inflammatory Endotypes Using Repeated Sputum Eosinophil Counts
by: Augusta Beech, et al.
Published: (2022-10-01)

Blood eosinophil count predicts treatment failure and hospital readmission for COPD
by: Marjan Kerkhof, et al.
Published: (2020-11-01)

Copd in the ed: eosinophils, treatment and outcomes, data from the pre-award study
by: Russell, R, et al.
Published: (2016)

Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPD
by: Song JH, et al.
Published: (2017-08-01)

Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
by: George, L, et al.
Published: (2019)

Neutrophil elastase as a biomarker for bacterial infection in COPD
by: Thulborn, S, et al.
Published: (2019)

Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization
by: Bélanger M, et al.
Published: (2018-10-01)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
by: Bafadhel, M, et al.
Published: (2016)

Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
by: Barker, R, et al.
Published: (2017)

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
by: Cheng SL, et al.
Published: (2016-09-01)

Blood eosinophil and neutrophil counts differentially identify frequent exacerbation in patients with COPD with physician-diagnosed asthma and COPD
by: Takao Mochimaru, et al.
Published: (2021-04-01)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
by: Eltboli, O, et al.
Published: (2014)

Symptomatic COPD: is it time for triple therapy?
by: Bafadhel, M
Published: (2018)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
by: Camp, J, et al.
Published: (2018)